$23.60
2.03% yesterday
NYSE, Sep 25, 10:15 pm CET
ISIN
US7170811035
Symbol
PFE

Pfizer Stock price

$23.60
-1.54 6.13% 1M
-1.95 7.63% 6M
-2.93 11.04% YTD
-5.33 18.42% 1Y
-20.23 46.16% 3Y
-10.55 30.89% 5Y
-6.61 21.88% 10Y
-0.26 1.10% 20Y
NYSE, Closing price Thu, Sep 25 2025
-0.49 2.03%

Key metrics

Basic
Market capitalization
$137.0b
Enterprise Value
$185.5b
Net debt
$48.5b
Cash
$13.2b
Shares outstanding
5.7b
Valuation (TTM | estimate)
P/E
12.8 | 7.7
P/S
2.1 | 2.1
EV/Sales
2.9 | 2.9
EV/FCF
14.9
P/B
1.5
Dividends
DPS
$1.69
Yield 1Y | 5Y
7.0% | 4.2%
Growth 1Y | 5Y
2.4% | 4.1%
Payout 1Y | 3Y
119.9% | 68.3%
Increased
15 Years
Financials (TTM | estimate)
Revenue
$63.8b | $63.8b
EBITDA
$23.3b | $25.8b
EBIT
$18.2b | $21.9b
Net Income
$10.8b | $17.8b
Free Cash Flow
$12.4b
Growth (TTM | estimate)
Revenue
13.5% | 0.4%
EBITDA
45.0% | 17.1%
EBIT
65.4% | 30.8%
Net Income
514.3% | 121.6%
Free Cash Flow
158.5%
Margin (TTM | estimate)
Gross
74.0%
EBITDA
36.5% | 40.4%
EBIT
28.5%
Net
16.8% | 27.9%
Free Cash Flow
19.5%
Financial Health
Equity Ratio
41.3%
Return on Equity
9.1%
ROCE
10.8%
ROIC
11.5%
Debt/Equity
0.7
More
EPS
$1.9
FCF per Share
$2.2
Short interest
1.8%
Employees
81k
Rev per Employee
$790.0k
Show more

Is Pfizer a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,008 stocks worldwide.

Pfizer Stock Analysis

Unlock Scores for Free

Analyst Opinions

30 Analysts have issued a Pfizer forecast:

13x Buy
43%
16x Hold
53%
1x Sell
3%

Analyst Opinions

30 Analysts have issued a Pfizer forecast:

Buy
43%
Hold
53%
Sell
3%

Financial data from Pfizer

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
63,833 63,833
14% 14%
100%
- Direct Costs 16,621 16,621
5% 5%
26%
47,212 47,212
17% 17%
74%
- Selling and Administrative Expenses 13,896 13,896
6% 6%
22%
- Research and Development Expense 10,204 10,204
4% 4%
16%
23,297 23,297
45% 45%
36%
- Depreciation and Amortization 5,093 5,093
1% 1%
8%
EBIT (Operating Income) EBIT 18,204 18,204
65% 65%
29%
Net Profit 10,752 10,752
514% 514%
17%

In millions USD.

Don't miss a Thing! We will send you all news about Pfizer directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Pfizer Stock News

Neutral
Business Wire
about 9 hours ago
PENSACOLA, Fla.--(BUSINESS WIRE)--A hearing in the Depo-Provera legal action against Pfizer Inc. (NYSE:PFE) will take place on Monday, 29 September at 9:00am CT in the United States Courthouse in Pensacola, Florida. The hearing will address oral arguments from the plaintiffs and defendants concerning the issue of pre-emption. The pre-emption defence is common in drug litigation. It involves the...
Positive
Seeking Alpha
about 9 hours ago
Pfizer Inc. is acquiring Metsera for up to $7.2 billion, aiming to enter the weight-loss drug market despite late-stage entry and no ongoing Phase 3 trials. PFE's acquisition targets GLP-1-based obesity drugs but faces stiff competition from established players like Eli Lilly and Novo Nordisk and promising biotechs like Viking Therapeutics. The stock offers a compelling 7% dividend yield, suppo...
Neutral
The Motley Fool
about 15 hours ago
Remember Pfizer (PFE -0.46%), the giant pharmaceutical company that developed a COVID-19 vaccine within weeks of the pandemic hitting U.S. shores and got it approved within a year? It was the fastest vaccine development in history and a miracle of modern science.
More Pfizer News

Company Profile

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Head office United States
CEO Albert Bourla
Employees 81,000
Founded 1849
Website www.pfizer.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today